U.S. BioDefense Signs Agreement With DuPont (DD) Director Of Technology Commercialization And TechIAConnect As Stem Cell Technology Transfer Consultants

CITY OF INDUSTRY, Calif.--(BUSINESS WIRE)--Jan. 13, 2005--U.S. BioDefense, Inc. (OTCBB:UBDF) is pleased to announce today that it has retained the services of Dr. Robert R. Gruetzmacher and TechIAConnect and Associates as its Stem Cell Technology Transfer Consultants. The company has engaged the consultants' services to assist U.S. BioDefense in its Stem Cell technology transfer and commercialization initiative including a white paper in progress on industry participants Geron Corp. (Nasdaq:GERN), Aastrom Biosciences (Nasdaq:ASTM), and StemCells, Inc. (Nasdaq:STEM). Dr. Gruetzmacher is the Director of Intellectual Property and Licensing in DuPont's Center for Collaborative Research and Education. For a recent interview with Dr. Gruetzmacher on Licensing at DuPont visit http://www.yet2.com/app/insight/insight/20011021_gruetzmacher .

Back to news